Position in ABBV
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,609,426
-$160,914 QoQ
Shares Held
7,400
-4.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GM Advisory Group, LLC holds $19,630,085 across 10 Drug Manufacturers - General names. ABBV ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,002 | $9,199,539 | |
| 2 | JNJ |
Johnson & Johnson
|
14,495 | $3,543,157 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,762 | $2,136,590 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
7,400 | $1,609,426 | |
| 5 | PFE |
Pfizer Inc
|
32,594 | $915,239 | |
| 6 | AMGN |
Amgen Inc
|
2,556 | $899,328 | |
| 7 | AZN |
Astrazeneca PLC
|
2,421 | $477,469 | |
| 8 | NVS |
Novartis AG
|
2,102 | $321,080 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,609,426 | 7,400 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,770,340 | 7,748 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,527,237 | 6,596 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $1,267,970 | 6,831 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $768,309 | 3,667 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $637,943 | 3,590 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $500,414 | 2,534 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $387,292 | 2,258 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $420,286 | 2,308 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $346,822 | 2,238 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $363,408 | 2,438 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $426,824 | 3,168 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $531,817 | 3,337 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $479,335 | 2,966 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $358,474 | 2,671 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $422,874 | 2,761 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $494,759 | 3,052 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $413,240 | 3,052 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $393,941 | 3,652 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $513,976 | 4,563 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $422,058 | 3,900 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,868,803 | 17,441 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,583,627 | 18,080 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,721,095 | 17,530 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||